Colombia covers liraglutide for high-BMI cases but imposes multi-step prior authorization
Ohkubo, M., Ohta, K., Inoue, K
Talasaz A, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom J, Siegal D, Monreal M, Jimenez D, Vaduganathan M, Castellucci L, Cuker A, Barnes G, Connors J, Secemsky E, Van Tassell B, De Caterina R, Kurlander J, Aminian A, Piazza G, Goldhaber S, Moores L, Middeldorp S, Kirtane A, Elkind M, Angiolillo D, Konstantinides S, Lip G, Stone G, Cushman M, Krumholz H , Mehran R, Bhatt D, Bikdeli B
Compounding pharmacies and outsourcing facilities generated billions in revenue, servicing millions of patients unable to access or afford brand-name therapies
The distinctive value of PET imaging lies in its capacity to provide non-invasive, visual evidence of neuroinflammation, thereby directly linking peripheral immune activation with central clinical manifestations, such as brain fog and cognitive decline, while also revealing the heterogeneity within patient populations
Semaglutide and tirzepatide are available now, while retatrutide remains in trials, so the practical comparison for most patients today is between the two approved options
